Acceptability of prophylactic human papillomavirus vaccination among adult men

作者：Hernandez Brenda Y^*; Wilkens L R; Thompson P J; Shvetsov Y B; Goodman M T; Ning L; Kaopua L

来源：Human Vaccines, 2010, 6(6): 467-475.

DOI：10.4161/hv.6.6.11279

• human papillomavirus
• vaccination
• vaccine
• males
• acceptability

Objectives: HPV vaccine acceptability was examined as part of a cohort study of HPV infection among adult males.
Results: Overall, 69% of men reported that they were likely or very likely to be vaccinated against HPV if a prophylactic vaccine were available. Men most frequently cited side effects (69%), efficacy (65%) and safety (63%) as the major factors that would influence their decision to be vaccinated against HPV. Issues of vaccine costs and efficacy were important considerations for men of vaccine-eligible ages (18-26 years).
Men who cited cost as a major factor in their HPV vaccine decisions and those indicating cost as a potential barrier had greater intention to be vaccinated. Heterosexual men had less intention to be vaccinated compared to men who have sex with men.
Methods: Between July 2004 and June 2007, 445 adult males aged >= 18 years were enrolled primarily from a university-based population. A structured questionnaire addressed HPV vaccine awareness, attitudes and intention to be vaccinated.
Conclusion: Acceptability of HPV vaccination among males is generally high. Costs and sexual history may influence vaccine utilization.

• 出版日期2010-6